Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 1;4(10):1430-1436.
doi: 10.34067/KID.0000000000000241. Epub 2023 Sep 8.

Phenotypes of Symptom, Function, and Medication Burden in Older Adults with Nondialysis Advanced Kidney Disease

Affiliations

Phenotypes of Symptom, Function, and Medication Burden in Older Adults with Nondialysis Advanced Kidney Disease

Jessica E Ma et al. Kidney360. .

Abstract

Key Points:

  1. There are three distinct classes of symptoms, functional impairment, and medication burden among older adults with advanced kidney disease.

  2. One class with Complex Needs with pain and psychological symptoms, functional difficulties, and polypharmacy may benefit from tailored multidisciplinary care.

Background: Older adults with advanced CKD (stages 4 and 5) have significant symptoms, polypharmacy, and functional difficulties, and previous studies evaluated these burdens separately. Identifying subgroups with similar patterns of burdens could help clinicians optimize care for these individuals.

Methods: We conducted a secondary analysis of 377 older participants (70 years and older) with stage 4 and 5 CKD at high risk of hospitalization enrolled in a national Veterans Affairs prospective cohort study. Adults on dialysis or with prior kidney transplant were excluded. We used latent class analysis to identify participants with similar patterns across symptoms, medication burden, and function. Sixteen variables were included: symptoms (anxiety, depression, appetite, pain, shortness of breath, fatigue, dizziness, leg weakness, constipation, and stiffness using the Symptom Burden Score), polypharmacy (≥10 medications and potentially inappropriate medications), and function (activities of daily living [ADLs], physical and cognitive instrumental ADLs [IADLs], and falls in the past year). We also compared 12-month hospitalization and mortality rates between the three classes.

Results: Three classes of participants with similar functional impairment, medication burden, and symptom phenotypes were identified. The largest participant class (N=208) primarily had difficulties with physical IADLs and polypharmacy. The second participant class (N=99) had shortness of breath, constipation, and dizziness. The third participant class (N=70) had complex needs with daily pain, psychological symptoms (anxiety and depression), functional limitations (ADLs and physical and cognitive IADLs), and polypharmacy. The three classes had significantly different levels of comorbidities, financial stress, and social support. There were no significant differences in mortality and hospitalization among the three classes.

Conclusion: There are distinct classes of older adults with advanced CKD who have physical and psychological symptoms, functional impairment, and medication burden. Tailoring care for this population should include a multidisciplinary team to address these overlapping symptoms, medication, and functional needs.

PubMed Disclaimer

Conflict of interest statement

All authors have nothing to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Item response probabilities by latent class and variables. Item response probabilities are the model's estimated probability of a participant endorsing the 16 symptoms, medication burden, and functional impairment items conditional on class membership. Item response probabilities >0.7 are shown in blue. ADL, activity of daily living; IADL, instrumental activity of daily living.

References

    1. Brown SA Tyrer FC Clarke AL, et al. . Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy. Clin Kidney J. 2017;10(6):788–796. doi:10.1093/ckj/sfx057 - DOI - PMC - PubMed
    1. Murtagh FEM, Sheerin NS, Addington-Hall J, Higginson IJ. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011;6(7):1580–1590. doi:10.2215/CJN.09021010 - DOI - PubMed
    1. van Oosten MJM Logtenberg SJJ Hemmelder MH, et al. . Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls. Clin Kidney J. 2021;14(12):2497–2523. doi:10.1093/ckj/sfab120 - DOI - PMC - PubMed
    1. Fried LF Lee JS Shlipak M, et al. . Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006;54(5):750–756. doi:10.1111/j.1532-5415.2006.00727.x - DOI - PubMed
    1. Blum M, McKendrick K, Gelfman LP, Pinney SP, Goldstein NE. Using latent class analysis to identify different clinical profiles among patients with advanced heart failure. J Pain Symptom Manage. 2023;65(2):111–119. doi:10.1016/j.jpainsymman.2022.10.011 - DOI - PMC - PubMed

Publication types

LinkOut - more resources